FDA Clearance Tracker · K210616
Longeviti PMMA Static Cranial Implant
Last checked: Nov 19, 2026Latest source record: Mar 31, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Mar 31, 2021
Substantially Equivalent
Time to decision
30 days
Received Mar 1, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K210616
- Device name
- Longeviti PMMA Static Cranial Implant
- Applicant
- Longeviti Neuro Solutions, LLC
- Applicant location
- Hunt Valley, MD
- Received
- Mar 1, 2021
- Decided
- Mar 31, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5330
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXN. The earliest in FDA's data is K972332, decided Jan 16, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210616
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Longeviti Neuro Solutions, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231920 · Decided Nov 9, 2023 · 133 days after receipt
Device type: Plate, Cranioplasty, Preformed, Non-Alterable (GXN) · Neurology & Neurosurgery
K212058 · Decided Sep 8, 2021 · 69 days after receipt
Device type: Plate, Cranioplasty, Preformed, Non-Alterable (GXN) · Neurology & Neurosurgery
K211514 · Decided Jul 15, 2021 · 59 days after receipt
Device type: Material, Polytetrafluoroethylene Vitreous Carbon, For Maxillofacial Reconstruction (KKY) · General & Plastic Surgery
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.